Article Information
History
- January 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David Mallet1,
- Raphael Goutaudier1,
- Emmanuel L. Barbier1,3,
- Sebastien Carnicella1,
- Jerry R. Colca2,
- Florence Fauvelle*,1,3 and
- Sabrina Boulet*,1,#
- 1Université Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, 38000 Grenoble, France
- 2Metabolic Solutions Development Company, Kalamazoo, MI 49007, USA
- 3Université Grenoble Alpes, Inserm, US17, CNRS, UMS 3552, CHU Grenoble Alpes, IRMaGe, Grenoble, France
- ↵#Correspondence: sabrina.boulet{at}univ-grenoble-alpes.fr
Posted January 20, 2022.
Re-routing metabolism by the mitochondrial pyruvate carrier inhibitor MSDC-0160 attenuates neurodegeneration in a rat model of Parkinson’s disease
